Pulling SEC filings + quote and writing the call…
VIR
Vir Biotechnology, Inc.
Next earnings Aug 4, 2026 · consensus $0.33 EPS, $219M rev
Last earnings +2.8% on 2026-05-06
$9.16
▼ -1.51%$9.16▲ +74.81%
over 1Y
L $4.28EODHDH $11.09
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today-1.5%
1W+7.5%
1M+7.4%
3M-2.3%
YTD+54.2%
1Y+74.8%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 14 analysts
Buy
Conservative balance sheet (liabilities/equity 0.31x); but revenue declined -7.6% YoY.
Vir Biotechnology, Inc. shows $68.6M in FY2025 revenue (-7.6% YoY), a -638.9% net margin, and -57.2% ROE.
Sources: SEC EDGAR (CIK 0001706431, latest 10-Q filed 2026-05-07) · EODHD · as of 6/22/2026, 9:52:11 AM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.